Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of vasodilatory effects of ciprofol vs propofol at ED50 using perfusion index
ChiCTR2600127001Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Jun 2026
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofol and propofol in None (4 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoints: Perfusion index (PI) at 1, 2, and 3 minutes after administration, Rate of change of perfusion index (PI) and 1 more. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
ciprofolpropofol
Beyond the preview
Go deeper on ChiCTR2600127001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127001.